On Monday, Equillium Inc (NASDAQ: EQ) opened higher 21.74% from the last session, before settling in for the closing price of $1.15. Price fluctuations for EQ have ranged from $0.27 to $2.35 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 31.13% over the past five years. Company’s average yearly earnings per share was noted -86.96% at the time writing. With a float of $43.57 million, this company’s outstanding shares have now reached $60.68 million.
Equillium Inc (EQ) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Equillium Inc is 28.45%, while institutional ownership is 48.39%. The most recent insider transaction that took place on Dec 12 ’25, was worth 31,897. In this transaction Sr. Vice President and COO of this company sold 23,804 shares at a rate of $1.34, taking the stock ownership to the 103,344 shares. Before that another transaction happened on Dec 15 ’25, when Company’s Sr. Vice President and COO sold 11,900 for $1.31, making the entire transaction worth $15,589. This insider now owns 91,444 shares in total.
Equillium Inc (EQ) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.16 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.31) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -86.96% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.47% during the next five years compared to 31.13% growth over the previous five years of trading.
Equillium Inc (NASDAQ: EQ) Trading Performance Indicators
Check out the current performance indicators for Equillium Inc (EQ). In the past quarter, the stock posted a quick ratio of 10.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.63, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Equillium Inc (EQ)
Equillium Inc (NASDAQ: EQ) saw its 5-day average volume 1.14 million, a negative change from its year-to-date volume of 2.6 million. As of the previous 9 days, the stock’s Stochastic %D was 56.50%.
During the past 100 days, Equillium Inc’s (EQ) raw stochastic average was set at 52.02%, which indicates a significant decrease from 81.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1525 in the past 14 days, which was lower than the 0.1869 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1480, while its 200-day Moving Average is $0.8642. Nevertheless, the first resistance level for the watch stands at $1.5366 in the near term. At $1.6733, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.8165. If the price goes on to break the first support level at $1.2567, it is likely to go to the next support level at $1.1135. The third support level lies at $0.9768 if the price breaches the second support level.
Equillium Inc (NASDAQ: EQ) Key Stats
There are currently 60,893K shares outstanding in the company with a market cap of 85.25 million. Presently, the company’s annual sales total 41,100 K according to its annual income of -8,070 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -4,230 K.
